Exilant 30 mg (Capsule (Enteric Coated))
Unit Price: ৳ 10.00 (3 x 10: ৳ 300.00)
Strip Price: ৳ 100.00
Medicine Details
Category | Details |
---|---|
Generic | Dexlansoprazole |
Company | Pharmasia limited |
Also available as |
Title
- Exilant Dexlansoprazole Delayed-Release Capsules
Categories
- Proton Pump Inhibitor
- Gastrointestinal Medication
Description
- Exilant Dexlansoprazole Delayed-Release Capsules help in the healing of erosive esophagitis, maintenance of healed erosive esophagitis, relief of heartburn, and treatment of symptomatic non-erosive Gastroesophageal Reflux Disease (GERD). It is available as a Dual Delayed Release (DDR) formulation in a capsule for oral administration.
Dimensions
- Capsule size: standard pharmaceutical capsule size
Color options
- Not applicable
Functions
- Healing of all grades of erosive esophagitis for up to 8 weeks
- Maintenance of healed erosive esophagitis and relief of heartburn for up to 6 months
- Treatment of heartburn associated with symptomatic non-erosive GERD for 4 weeks
Materials
- Active ingredient: Dexlansoprazole
- Capsule shell material: Not specified
Technical specifications
- Proton Pump Inhibitor (PPI)
- Suppression of gastric acid secretion by specific inhibition of the (H+/K+)-ATPase in the gastric parietal cell
- Dual Delayed Release (DDR) formulation with two types of enteric-coated granules with different pH-dependent dissolution profiles
Design elements
- Capsule formulation with enteric-coated granules
- Dual delayed release for distinctive plasma concentration-time profile
Usability features
- Can be taken without regard to food
- Can be swallowed whole or administered by sprinkling intact granules on one tablespoon and then swallowing immediately
Dosage recommendations
- Dexlansoprazole Capsules:
- Healing of erosive esophagitis: 60 mg once daily for up to 8 weeks
- Maintenance of healed erosive esophagitis and relief of heartburn: 30 mg once daily
- Symptomatic Non-Erosive GERD: 30 mg once daily for 4 weeks
- Dexlansoprazole MUPS:
- Maintenance of healed erosive esophagitis and relief of heartburn: One 30 mg tablet once daily for 6 months in adults and 16 weeks in patients 12 to 17 years of age
- Symptomatic Non-Erosive GERD: One 30 mg tablet once daily for 4 weeks
Administration methods
- Swallowing the capsule whole
- Oral administration by sprinkling intact granules on one tablespoon and then swallowing immediately
Interactions
- With medicine:
- Atazanavir
- Warfarin
- Tacrolimus
- Clopidogrel
- Methotrexate
- With food & others:
- No data available
Contraindications
- Known hypersensitivity to any component of the formulation
Side effects
- Diarrhea
- Abdominal pain
- Nausea
- Vomiting
- Flatulence
Pregnancy and lactation
- Pregnancy Category B
- No adequate and well-controlled studies with Dexlansoprazole in pregnant women or lactating mothers
Precautions and warnings
- Gastric Malignancy
- Clostridium difficile Associated Diarrhea
- Bone fracture
- Hypomagnesemia
- Concomitant use of Exilant with Methotrexate
Special population use
- Children & adolescents: Safety and effectiveness not established for patients below 12 years of age
- Geriatric use: No dose adjustment necessary
- Renal impairment: No dose adjustment necessary
- Hepatic impairment: No dose adjustment necessary for mild hepatic impairment; consideration of a maximum daily dose of 30 mg for moderate hepatic impairment
Overdose effects
- No reports of significant overdose
- Multiple doses of 120 mg and a single dose of 300 mg did not result in severe adverse events
Therapeutic class
- Proton Pump Inhibitor
Storage conditions
- Store below 30°C and in a dry place
- Protect from light
- Keep out of reach of children
Related Brands
- Dexilend 30 mg (Capsule (Enteric Coated)) - ziska-pharmaceuticals-ltd
- Dexilend 60 mg (Capsule (Enteric Coated)) - ziska-pharmaceuticals-ltd
- Dexlan 30 mg (Capsule (Enteric Coated)) - ibn-sina-pharmaceuticals-ltd
- Dexlan 60 mg (Capsule (Enteric Coated)) - ibn-sina-pharmaceuticals-ltd
- Desopra 30 mg (Capsule (Enteric Coated)) - alco-pharma-ltd